The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasetti-Escargueil, Christine, Avril, Arnaud, Miethe, Sebastian, Mazuet, Christelle, Derman, Yagmur, Selby, Katja, Thullier, Philippe, Pelat, Thibaut, Urbain, Remi, Fontayne, Alexandre, Korkeala, Hannu, Sesardic, Dorothea, Hust, Michael, Popoff, Michel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666356/
https://www.ncbi.nlm.nih.gov/pubmed/28974033
http://dx.doi.org/10.3390/toxins9100309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666356/
https://www.ncbi.nlm.nih.gov/pubmed/28974033
http://dx.doi.org/10.3390/toxins9100309

Ejemplares similares